Renders L, Schöcklmann H, Kunzendorf U
Klinik für Nieren- und Hochdruckkrankheiten, Universitätsklinikum Schleswig-Holstein, Campus Kiel.
Internist (Berl). 2004 Aug;45(8):882-92. doi: 10.1007/s00108-004-1234-3.
The risk to acquire opportunistic infections is clearly increased in patients receiving immunosuppressive therapeutic regimens following organ transplantation or during treatment of autoimmune disorders. The modulation of the immune system can alter the clinical symptoms and the course of infectious diseases, including diagnostic signs such as fever or pathological changes in radiographs or blood cell counts. However, a rapid diagnosis and start of treatment is essential in these patients. Thus, a correct interpretation of even mild symptoms in the initial phase of an infectious disease is essential for establishing a diagnosis and initiation of a therapy at an early stage. Therefore, it is necessary that the clinical hallmarks of these diseases are widely known and that physicians treating these patients cooperate closely with transplant centers.
接受器官移植后或自身免疫性疾病治疗期间接受免疫抑制治疗方案的患者发生机会性感染的风险明显增加。免疫系统的调节可改变临床症状以及传染病的病程,包括发热、X光片或血细胞计数的病理变化等诊断体征。然而,对这些患者而言,快速诊断并开始治疗至关重要。因此,正确解读传染病初期即使是轻微的症状对于早期确诊和开始治疗至关重要。所以,有必要让这些疾病的临床特征广为人知,并且治疗这些患者的医生要与移植中心密切合作。